Literature DB >> 18219819

Remyelination in experimental models of toxin-induced demyelination.

W F Blakemore1, R J M Franklin.   

Abstract

Remyelination is the regenerative process by which demyelinated axons are reinvested with new myelin sheaths. It is associated with functional recovery and maintenance of axonal health. It occurs as a spontaneous regenerative response following demyelination in a range of pathologies including traumatic injury as well as primary demyelinating disease such as multiple sclerosis (MS). Experimental models of demyelination based on the use of toxins, while not attempting to accurately mimic a disease with complex etiology and pathogenesis such as MS, have nevertheless proven extremely useful for studying the biology of remyelination. In this chapter, we review the main toxin models of demyelination, drawing attention to their differences and how they can be used to study different aspects of remyelination. We also describe the optimal use of these models, highlighting potential pitfalls in interpretation, and how remyelination can be unequivocally recognized. Finally, we discuss the role of toxin models alongside viral and immune-mediated models of demyelination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18219819     DOI: 10.1007/978-3-540-73677-6_8

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  93 in total

1.  The relevance of animal models in multiple sclerosis research.

Authors:  Aleksandar Denic; Aaron J Johnson; Allan J Bieber; Arthur E Warrington; Moses Rodriguez; Istvan Pirko
Journal:  Pathophysiology       Date:  2011-02

Review 2.  Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models.

Authors:  Robert H Miller; Sharyl L Fyffe-Maricich
Journal:  Dis Model Mech       Date:  2010-07-20       Impact factor: 5.758

3.  Towards improved animal models of neonatal white matter injury associated with cerebral palsy.

Authors:  John C Silbereis; Eric J Huang; Stephen A Back; David H Rowitch
Journal:  Dis Model Mech       Date:  2010 Nov-Dec       Impact factor: 5.758

4.  Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia.

Authors:  Daniel J Webber; Marka van Blitterswijk; Siddharthan Chandran
Journal:  Am J Pathol       Date:  2009-10-22       Impact factor: 4.307

5.  Downregulating DR6 to drive remyelination.

Authors:  Brian Popko
Journal:  Nat Med       Date:  2011-07-07       Impact factor: 53.440

6.  Stimulation of adult oligodendrogenesis by myelin-specific T cells.

Authors:  Helle Hvilsted Nielsen; Henrik Toft-Hansen; Kate Lykke Lambertsen; Trevor Owens; Bente Finsen
Journal:  Am J Pathol       Date:  2011-08-26       Impact factor: 4.307

7.  Evaluation of a transgenic mouse model of multiple sclerosis with noninvasive methods.

Authors:  Mabel Enriquez-Algeciras; Di Ding; Tsung-Han Chou; Jianhua Wang; Kyle R Padgett; Vittorio Porciatti; Sanjoy K Bhattacharya
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-14       Impact factor: 4.799

8.  Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.

Authors:  Andrew V Caprariello; Saisho Mangla; Robert H Miller; Stephen M Selkirk
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

Review 9.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

10.  Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS.

Authors:  Stephen P J Fancy; Sergio E Baranzini; Chao Zhao; Dong-In Yuk; Karen-Amanda Irvine; Sovann Kaing; Nader Sanai; Robin J M Franklin; David H Rowitch
Journal:  Genes Dev       Date:  2009-06-10       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.